Topvision Eye Specialist BhdXKLS:0332 +3.03%53 PE Ratio without NRI is 42.50 as of Jul. 05, 2026, which is 49% below its 10-year median of 83.33. GuruFocus rates XKLS:0332 with a GF Score™ of 53/100 and a GF Value™ of RM0.68 (Significantly Undervalued). The stock has 8 warning signs investors should review. Among 437 Healthcare Providers & Services companies, Topvision Eye Specialist Bhd ranks worse than 76.89% on this metric.
The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-07-05), Topvision Eye Specialist Bhd's share price is RM0.17.
Topvision Eye Specialist Bhd's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was RM0.00. Therefore, Topvision Eye Specialist Bhd's PE Ratio without NRI for today is 42.50.
During the past 11 years, Topvision Eye Specialist Bhd's highest PE Ratio without NRI was 250.00. The lowest was 23.08. And the median was 83.33.
Topvision Eye Specialist Bhd (XKLS:0332) PE Ratio without NRI Explanation
The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.
If a company loses money, the PE Ratio becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.
Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.
Topvision Eye Specialist Bhd PE Ratio without NRI Related Terms
Topvision Eye Specialist Bhd PE Ratio without NRI Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Topvision Eye Specialist Bhd PE Ratio without NRI Chart
XKLS:0332 vs HCA, THC, DVA: PE Ratio without NRI Comparison
For the Medical Care Facilities subindustry, Topvision Eye Specialist Bhd's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Topvision Eye Specialist Bhd PE Ratio without NRI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Topvision Eye Specialist Bhd's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Topvision Eye Specialist Bhd's PE Ratio without NRI falls into.
Topvision Eye Specialist Bhd PE Ratio without NRI Calculation
The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.
Topvision Eye Specialist Bhd's Share Price of today is RM0.17.
Topvision Eye Specialist Bhd's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.
For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Topvision Eye Specialist Bhd (XKLS:0332) has a PE Ratio without NRI of 42.50 as of Jul. 05, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Topvision Eye Specialist Bhd and its competitors. This is 49% below median its historical median of 83.33. Over the past decade, Topvision Eye Specialist Bhd's PE Ratio without NRI has ranged from 23.08 to 250.00. According to the industry distribution chart, Topvision Eye Specialist Bhd ranks #336 out of 437 companies in the Healthcare Providers & Services industry, placing it in the top 76.9%.
Is Topvision Eye Specialist Bhd's PE Ratio without NRI too high?
Topvision Eye Specialist Bhd's current PE Ratio without NRI of 42.50 is 49% below median its 10-year median of 83.33. Over the past 10 years, this metric has ranged from a low of 23.08 to a high of 250.00. The Healthcare Providers & Services industry median PE Ratio without NRI is 20.03. Topvision Eye Specialist Bhd's value of 42.50 is 112.2% above this industry median. Based on the distribution chart, Topvision Eye Specialist Bhd ranks #336 out of 437 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Topvision Eye Specialist Bhd has a GF Score™ of 53/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Topvision Eye Specialist Bhd's PE Ratio without NRI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Topvision Eye Specialist Bhd ranks #336 out of 437 companies for PE Ratio without NRI. This places Topvision Eye Specialist Bhd in the lower half of its industry. The industry median PE Ratio without NRI is 20.03. Topvision Eye Specialist Bhd's value of 42.50 is 112.2% above this benchmark. Historically, Topvision Eye Specialist Bhd's own PE Ratio without NRI has ranged from 23.08 to 250.00 over the past decade. While the company's 10-year median is 83.33 vs. the industry median of 20.03, Topvision Eye Specialist Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Healthcare Providers & Services company?
The median PE Ratio without NRI among Healthcare Providers & Services companies is 20.03, based on 437 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Topvision Eye Specialist Bhd's current PE Ratio without NRI of 42.50 is 112.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Topvision Eye Specialist Bhd and its competitors. For the Healthcare Providers & Services industry, the median PE Ratio without NRI is 20.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Topvision Eye Specialist Bhd's current PE Ratio without NRI is 42.50, which is 49% below median its own 10-year median of 83.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Topvision Eye Specialist Bhd stock overvalued right now?
Based on GuruFocus' analysis, Topvision Eye Specialist Bhd (XKLS:0332) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.68, compared to a current price of RM0.17 — trading 75% below its estimated fair value. The current PE Ratio without NRI is 42.50, which is 49% below median its 10-year median of 83.33 and 112.2% above the Healthcare Providers & Services industry median of 20.03. Topvision Eye Specialist Bhd's overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Topvision Eye Specialist Bhd (XKLS:0332), the current PE Ratio without NRI is 42.50 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Topvision Eye Specialist Bhd (XKLS:0332) Overvalued in 2026?
Based on GuruFocus' analysis, Topvision Eye Specialist Bhd stock appears to be undervalued.
The current stock price of RM0.17 is trading 75% below its estimated GF Value™ of RM0.68.
GuruFocus considers Topvision Eye Specialist Bhd to be Significantly Undervalued.
Key valuation signals for XKLS:0332:
PE Ratio without NRI: 42.50 (49% below median its 10-year median of 83.33)
GF Value™: RM0.68 vs. price of RM0.17 (75% below fair value)
Industry Position: 112.2% above the Healthcare Providers & Services median (#336 of 437)
No single metric tells the full story. See the XKLS:0332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Topvision Eye Specialist Bhd is principally involved in the provision of ophthalmology services and related medical consultancy services. The company is also engaged in the marketing of eye supplements and health food products. The company derives a majority of its revenue from its ophthalmology services business, providing treatments for general as well as complex eye diseases. Geographically, it operates in Malaysia.
53GF Score
Get the complete analysis for XKLS:0332
PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0332 has been successfully added to your 
